About Radiofrequency Ablation Devices Radiofrequency ablation devices are used to treat medical conditions such as cancer tumours with help of imaging techniques such as computed tomography, magnetic resonance imaging, and ultrasound by using MI techniques. This involves high frequency electromagnetic waves by generating heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, to remove or trim obstructive tissues, and deaden nerves. The process is carried by inserting a special needle through the skin onto the tumour and targeted to the specific tissue/nerve with radiofrequency electrical energy to heat the tumour through an active exposed electrode tip. The heating generated induces cellular death as a result of irreversible protein denaturation. This technology has wide applications and is used in various medical fields such as cardiac rhythm, oncology, cerebral tumours, gynecology, and renal denervation for hypertension, pain management, and cosmetology. TechNavio's analysts forecast the Global Radiofrequency Ablation Devices market to grow at a CAGR of 18.24 percent over the period 2014-2019. Covered in this Report This report covers... Research Beam Model: Research Beam Product ID: 170822 2500 USD New
Global Radiofrequency Ablation Devices Market 2015-2019
 

Global Radiofrequency Ablation Devices Market 2015-2019

Global Radiofrequency Ablation Devices Market 2015-2019

Category : Medical Devices
Published On : January  2015
Pages : 87

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Radiofrequency Ablation Devices  
Radiofrequency ablation devices are used to treat medical conditions such as cancer tumours with help of imaging techniques such as computed tomography, magnetic resonance imaging, and ultrasound by using MI techniques. This involves high frequency electromagnetic waves by generating heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, to remove or trim obstructive tissues, and deaden nerves. The process is carried by inserting a special needle through the skin onto the tumour and targeted to the specific tissue/nerve with radiofrequency electrical energy to heat the tumour through an active exposed electrode tip. The heating generated induces cellular death as a result of irreversible protein denaturation. This technology has wide applications and is used in various medical fields such as cardiac rhythm, oncology, cerebral tumours, gynecology, and renal denervation for hypertension, pain management, and cosmetology. 

TechNavio's analysts forecast the Global Radiofrequency Ablation Devices market to grow at a CAGR of 18.24 percent over the period 2014-2019.

Covered in this Report
This report covers the present scenario and growth prospects of the Global Radiofrequency Ablation Devices market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of radiofrequency ablation devices. Radiofrequency ablation devices have been segmented based on the type of technology and type of equipment as mentioned below: 

Technology
• Surgical Oncology
• Cardiology & Cardiac Rhythm Management
• Gynecology
• Hypertension
• Cosmetology
• Pain Management

Equipment
• Disposable Equipment
• Capital Equipment
• Reusable Equipment

The report presents the vendor landscape and a corresponding detailed analysis of the top 6 vendors in the Global Radiofrequency Ablation Devices market. The vendor landscape in this report focusses on the vendors that provide access to new and innovative technologically advanced radiofrequency ablation devices. The report also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
TechNavio's report, Global Radiofrequency Ablation Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Radiofrequency Ablation Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key Regions
• Americas 
• APAC
• EMEA
        
Key Vendors
• Angiodynamics 
• Boston Scientific 
• Covidien 
• Medtronic
• St Jude Medical 
• Stryker 

Other Prominent Vendor 
• Advanced Cardiac Therapeutics
• AtriCure
• BIOTRONIK 
• CardioFocus
• Edwards Lifesciences 
• Imricor Medical Systems 
• MicroPort Scientific 
• PLC Medical Systems
• Spacelabs Healthcare
• Suzuken
• Vimecon
• Welch Allyn

Market Driver
• Rise in Aging Population
• For a full, detailed list, view our report

Market Challenge
• Lack of Skilled Electrophysiologists
• For a full, detailed list, view our report

Market Trend
• Rise in Adoption of Radiofrequency Ablation Procedures
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Equipment Type
07.1 Disposable Equipment Market
07.1.1 Market Size and Forecast
07.2 Capital Equipment Market
07.2.1 Market Size and Forecast
07.3 Reusable Equipment Market
07.3.1 Market Size and Forecast
08. Market Segmentation by Application
09. Geographical Segmentation
09.1 Radiofrequency Ablation Devices Market in Americas
09.1.1 Market Size and Forecast
09.2 Radiofrequency Ablation Devices Market in EMEA Region
09.2.1 Market Size and Forecast
09.3 Radiofrequency Ablation Devices Market in APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 AngioDynamics
18.1.1 Key Facts
18.1.2 Business Overview/ Description
18.1.3 Business Segmentation
18.1.4 Business Strategy
18.1.5 Revenue Segmentation by Business /Products
18.1.6 Sales by Geographical Segmentation
18.1.7 Key Information
18.1.8 SWOT Analysis
18.2 Boston Scientific
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation
18.2.4 Business Segmentation by Revenue 2013
18.2.5 Business Segmentation by Revenue 2012 and 2013
18.2.6 Sales by Geography
18.2.7 Business Strategy
18.2.8 Key Developments
18.2.9 SWOT Analysis
18.3 Covidien
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue 2013
18.3.6 Business Strategy
18.3.7 Key Information
18.3.8 SWOT Analysis
18.4 Medtronic
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation
18.4.4 Revenue by Business Segmentation
18.4.5 Revenue Comparison by Business Segmentation 2012 and 2013
18.4.6 Revenue by Geographical Segmentation
18.4.7 Business Strategy
18.4.8 Key Developments
18.4.9 SWOT Analysis
18.5 Stryker
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation
18.5.4 Business Segmentation by Revenue 2013
18.5.5 Sales by Geography
18.5.6 Business Strategy
18.5.7 Key Information
18.5.8 SWOT Analysis
18.6 St. Jude Medical
18.6.1 Key Facts
18.6.2 Business Overview
18.6.3 Business Segmentation
18.6.4 Business Segmentation by Revenue 2013
18.6.5 Sales by Geography
18.6.6 Business Strategy
18.6.7 Key Information
18.6.8 SWOT Analysis
19. Other Reports in this Series



List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Radiofrequency Ablation Devices Market 2014-2019 (US$ million)
Exhibit 3: Global Radiofrequency Ablation Devices Market Segmentation by Equipment Type
Exhibit 4: Global Radiofrequency Ablation Devices by Segmentation by Equipment Type in 2014
Exhibit 5: Global Radiofrequency Ablation Devices by Segmentation by Equipment Type in 2019
Exhibit 6: Segmentation of Global Radiofrequency Ablation Devices Market by Equipment Type 2014-2019 (US$ million)
Exhibit 7: Segmentation of Global Radiofrequency Ablation Devices Market by Equipment Type 2014-2019
Exhibit 8: Disposable Equipment Market 2014-2019 (US$ million)
Exhibit 9: Capital Equipment Market 2014-2019 (US$ million)
Exhibit 10: Reusable Equipment Market 2014-2019 (US$ million)
Exhibit 11: Global Radiofrequency Ablation Devices Market Segmentation by Technology
Exhibit 12: Global Radiofrequency Ablation Devices by Geographical Segmentation 2014
Exhibit 13: Global Radiofrequency Ablation Devices by Geographical Segmentation 2019
Exhibit 14: Segmentation of Global Radiofrequency Ablation Devices Market by Geography 2014-2019 (US$ million)
Exhibit 15: Segmentation of Global Radiofrequency Ablation Devices Market by Geography 2014-2019
Exhibit 16: Radiofrequency Ablation Devices Market in Americas 2014-2019 (US$ million)
Exhibit 17: Radiofrequency Ablation Devices Market in EMEA 2014-2019 (US$ million)
Exhibit 18: Radiofrequency Ablation Devices Market in APAC 2014-2019 (US$ million)
Exhibit 19: Drivers for Global Radiofrequency Ablation Devices Market
Exhibit 20: AngioDynamics, Inc.: Business Segmentation by product Categories
Exhibit 21: AngioDynamics, Inc.: Revenue by Business Segmentation 2014
Exhibit 22: AngioDynamics, Inc.: Revenue Comparison by Geographical Segmentation 2014
Exhibit 23: Boston Scientific Corp.: Business Segmentation 2013
Exhibit 24: Boston Scientific Corp.: Business Segmentation by Revenue 2013
Exhibit 25: Boston Scientific Corp.: Business Segmentation by Revenue in 2012 and 2013 (US$ billion)
Exhibit 26: Boston Scientific Corp.: Sales by Geography 2013
Exhibit 27: Covidien: Business Segmentation 2013
Exhibit 28: Covidien: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 29: Covidien: Geographical Segmentation by Revenue 2013
Exhibit 30: Medtronic Inc.: Business Segmentation
Exhibit 31: Medtronic Inc.: Revenue by Business Segmentation 2013
Exhibit 32: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 33: Medtronic Inc.: Revenue by Geographical Segmentation 2013
Exhibit 34: Stryker Corp: Business Segmentation
Exhibit 35: Stryker Corp: Business Segmentation by Revenue 2013
Exhibit 36: Stryker Corp: Sales by Geography 2013
Exhibit 37: St. Jude Medical Inc.: Business Segmentation
Exhibit 38: St. Jude Medical Inc.: Business Segmentation by Revenue 2013
Exhibit 39: St. Jude Medical Inc.: Sales by Geography 2013



Enquiry Before Buy